Calhoun Lesley Ann 4
4 · Tango Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Calhoun Lesley Ann
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-05+37,500→ 37,500 totalExercise: $7.41Exp: 2034-06-05→ Common Stock (37,500 underlying) - Award
Common Stock
2024-06-05+6,250→ 11,250 total - Sale
Common Stock
2024-06-05$7.21/sh+5,000$36,039→ 6,250 total
Footnotes (4)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2023.
- [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $7.01 to $7.38 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F4]This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.